Global Pharmaceuticals & Biotech Leverage Leaders

Revolution Medicines

Market Cap: US$38.7b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Medpace Holdings

Market Cap: US$15.3b

Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.

PharmaResearch

Market Cap: ₩3.6t

Operates as a biopharmaceutical company primarily in South Korea.

Daiichi Sankyo Company

Market Cap: JP¥4.8t

Manufactures and sells pharmaceutical products in Japan and internationally.

Innovent Biologics

Market Cap: HK$139.1b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Eisai

Market Cap: JP¥1.2t

Engages in the research, development, manufacture, and sale of pharmaceuticals in Japan.

Metis TechBio

Market Cap: HK$16.8b

Engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States.

Livzon Pharmaceutical Group

Market Cap: CN¥23.9b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

Haisco Pharmaceutical Group

Market Cap: CN¥67.7b

Researches, develops, manufactures, and sells pharmaceutical products primarily in China.

Parabilis Medicines

Market Cap: US$3.7b

Operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.

Orion Oyj

Market Cap: €10.0b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Beam Therapeutics

Market Cap: US$3.5b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Danaher

Market Cap: US$138.9b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Hansoh Pharmaceutical Group

Market Cap: HK$183.8b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Mankind Pharma

Market Cap: ₹1.0t

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.

ABL Bio

Market Cap: ₩6.0t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Astellas Pharma

Market Cap: JP¥3.9t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Ajanta Pharma

Market Cap: ₹422.6b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Santen Pharmaceutical

Market Cap: JP¥690.8b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Caliway Biopharmaceuticals

Market Cap: NT$154.1b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Apeloa PharmaceuticalLtd

Market Cap: CN¥19.2b

Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.

MGI Tech

Market Cap: CN¥21.0b

Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.

Duality Biotherapeutics

Market Cap: HK$17.1b

A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally.

Taysha Gene Therapies

Market Cap: US$2.0b

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central nervous system.

NewAmsterdam Pharma

Market Cap: US$3.9b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease.

Xenon Pharmaceuticals

Market Cap: US$5.8b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders.

Belite Bio

Market Cap: US$5.9b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.

Disc Medicine

Market Cap: US$2.8b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Sam Chun Dang Pharm

Market Cap: ₩5.6t

Engages in the manufacturing and sale of pharmaceutical products in South Korea.

Chengdu Olymvax Biopharmaceuticals

Market Cap: CN¥15.5b

Engages in the research and development, production, and sales of vaccines for human use in China.

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥25.5b

Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

Celltrion

Market Cap: ₩39.4t

A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥16.0b

Engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally.

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$81.7b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.